Of the eight patients with CRC, six had tumors harboring an NTRK1 gene fusion, with the fusion partner being TPM3 in three patients, and TPR, LMNA, and IRF2BP2 in one patient each. This evidence concerns the gene TPR and colorectal carcinoma.